The European Commission on Wednesday authorized the CCP virus vaccine developed by U.S. company Moderna, the second COVID-19 jab approved by the EU. The authorization follows a positive recommendation from the European Medicines Agency (EMA), which reached the decision after an assessment of the vaccine’s quality, safety, and efficacy. “We are providing more COVID-19 vaccines for Europeans,”  European Commission President Ursula von der Leyen said in a statement. “With the Moderna vaccine, the second one now authorized in the EU, we will have a further 160 million doses. And more vaccines will come.” Von der Leyen said the EU had secured up to 2 billion doses of potential COVID-19 vaccines, “more than enough” for the whole population of the 27-nation bloc. The European Commission signed a contract with Moderna on Nov. 25 to deliver 160 million doses between the first and the third quarters of 2021. These will add to …